Investigating the effect of the Myrtus plant in genital warts

Studying the effect of a topical natural product prepared from the leaves of the plant (Myrtus communis L) on the healing process of genital warts in men with genital warts compared to cryotherapy

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240620062193N1

Enrollment

Registered

2024-12-22

Start date

2024-12-01

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HPV.

Interventions

Intervention 1: Intervention group: Treatment group with natural topical product prepared from the leaves of the subject plant. Intervention 2: Intervention group: and the cryotherapy treatment group.

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Men between 18 and 50 years old, patient willingness to cooperate. the diagnosis is confirmed by clinical findings, the absence of immunodeficiency or autoimmune disease; lack of HIV infection; No long-term use of corticosteroids or immunosuppressive drugs and being a non-smoker Is.

Exclusion criteria

Exclusion criteria: Exclusion criteria will include non-satisfaction to participate in any stage of the study, side effects or allergic reactions caused by the topical natural product.

Design outcomes

Primary

Measure	Time frame
Number of lesions before treatment. Timepoint: At the beginning of the study and two, four, six and eight weeks after the treatment. Method of measurement: counting.;The size of the largest lesion before treatment. Timepoint: At the beginning of the study and two, four, six and eight weeks after the treatment. Method of measurement: ruler.;Duration of infection. Timepoint: At the beginning of the study. Method of measurement: by question.;Skin color. Timepoint: At the beginning of the study. Method of measurement: by view.	—

Measure

Time frame

Number of lesions before treatment. Timepoint: At the beginning of the study and two, four, six and eight weeks after the treatment. Method of measurement: counting.;The size of the largest lesion before treatment. Timepoint: At the beginning of the study and two, four, six and eight weeks after the treatment. Method of measurement: ruler.;Duration of infection. Timepoint: At the beginning of the study. Method of measurement: by question.;Skin color. Timepoint: At the beginning of the study. Method of measurement: by view.

—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactmehdi mirghazanfari

Artesh University of Medical Sciences

smmirghazanfari@gmail.com+98 21 4382 2449

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026